LONDON, ONTARIO -- (MARKET WIRE) -- March 28, 2007 -- Stellar Pharmaceuticals Inc., (TSX VENTURE: SLX)(OTCBB: SLXCF) (“Stellar”), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced that it plans to release its 2006 fourth quarter and year-end financial results prior to the opening of the stock market on Friday, March 30, 2007. Management will conduct a conference call that morning at 11:00 a.m. Eastern Time to discuss these results. Interested parties may participate in the call by dialing 877-461-2814 (in the United States) or 416-695-9753 (in Canada) approximately 10 minutes before the call is scheduled to begin and ask to be connected to the Stellar Pharmaceuticals Conference Call.
